Progressive Encephalomyelitis With Rigidity and Myoclonus: The First Pediatric Case With Glycine Receptor Antibodies

IMPORTANCE Progressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle spasms, hyperekplexia, and brainstem signs. Recently, glycine receptor alpha 1 antibodies have been described in adult patients with progressive encephalomyelitis with rigidity and myocl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA neurology 2013-04, Vol.70 (4), p.1-4
Hauptverfasser: Damásio, Joana, Leite, M. Isabel, Coutinho, Ester, Waters, Patrick, Woodhall, Mark, Santos, Manuela A, Carrilho, Inês, Vincent, Angela
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4
container_issue 4
container_start_page 1
container_title JAMA neurology
container_volume 70
creator Damásio, Joana
Leite, M. Isabel
Coutinho, Ester
Waters, Patrick
Woodhall, Mark
Santos, Manuela A
Carrilho, Inês
Vincent, Angela
description IMPORTANCE Progressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle spasms, hyperekplexia, and brainstem signs. Recently, glycine receptor alpha 1 antibodies have been described in adult patients with progressive encephalomyelitis with rigidity and myoclonus. We describe a pediatric case. OBSERVATIONS A 14-month-old child developed startle-induced episodes of generalized rigidity and myoclonus, axial hyperextension, and trismus, without impairment of consciousness. Episodes occurred during wakefulness and sleep, lasted seconds, and were accompanied by moaning, tachypnea, and oxygen desaturation. Imaging, cerebrospinal fluid, endocrine, metabolic, and genetic screening findings were normal or negative. She was treated with intravenous steroids and immunoglobulins with resolution of symptoms, but she relapsed weeks later. At this time, episodes were more severe. Glycine receptor alpha 1 antibodies were found in serum (titer of 1:200, later 1:320) and cerebrospinal fluid (titer of 1:2). Treatment was restarted with intravenous steroids and immunoglobulins, with major improvement, and she began treatment with oral steroids. She had 4 milder relapses, with improvement after treatment adjustments. CONCLUSIONS AND RELEVANCE To our knowledge, this is the first pediatric case of progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor alpha 1 antibodies, a potentially severe but treatable antibody-mediated neurological disorder.
doi_str_mv 10.1001/jamaneurol.2013.1872
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1325331449</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>1566613</ama_id><sourcerecordid>1325331449</sourcerecordid><originalsourceid>FETCH-LOGICAL-a275t-b142c8eb27be5428337ca60e855a73bf75d84b4114eb2ab6807622c86b6afe253</originalsourceid><addsrcrecordid>eNpFkE1LwzAch4MoTua-gIjk6GUzb00zbzI2FRRFJh5L0v7nIm0zk1Totzdjc-aSHJ7nF3gQuqRkQgmhN1-60S103tUTRiifUJWzI3TGqFRjSbP8-PAW0wEahfBF0lGECC5O0YBxrohS4gzFV-8-PYRgfwDP2xI2a127pofaRhvwh41r_GY_bWVjj3Vb4efelbVru3CLl2vAC-tDxK9QWR29LfFMB9hZ93Vf2hbwG6TR6Dy-a6M1rrIQztHJStcBRvt7iN4X8-XsYfz0cv84u3saa5ZncWyoYKUCw3IDmWCK87zUkoDKMp1zs8qzSgkjKBWJ0UYqkkuWDGmkXgHL-BBd73Y33n13EGLR2FBCXad2rgsF5QniVIhpQsUOLb0LwcOq2HjbaN8XlBTb5MV_8mKbvNgmT9rV_ofONFAdpL_ACbjYAcn-n8yklJTzX3F8iR8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1325331449</pqid></control><display><type>article</type><title>Progressive Encephalomyelitis With Rigidity and Myoclonus: The First Pediatric Case With Glycine Receptor Antibodies</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Damásio, Joana ; Leite, M. Isabel ; Coutinho, Ester ; Waters, Patrick ; Woodhall, Mark ; Santos, Manuela A ; Carrilho, Inês ; Vincent, Angela</creator><creatorcontrib>Damásio, Joana ; Leite, M. Isabel ; Coutinho, Ester ; Waters, Patrick ; Woodhall, Mark ; Santos, Manuela A ; Carrilho, Inês ; Vincent, Angela</creatorcontrib><description>IMPORTANCE Progressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle spasms, hyperekplexia, and brainstem signs. Recently, glycine receptor alpha 1 antibodies have been described in adult patients with progressive encephalomyelitis with rigidity and myoclonus. We describe a pediatric case. OBSERVATIONS A 14-month-old child developed startle-induced episodes of generalized rigidity and myoclonus, axial hyperextension, and trismus, without impairment of consciousness. Episodes occurred during wakefulness and sleep, lasted seconds, and were accompanied by moaning, tachypnea, and oxygen desaturation. Imaging, cerebrospinal fluid, endocrine, metabolic, and genetic screening findings were normal or negative. She was treated with intravenous steroids and immunoglobulins with resolution of symptoms, but she relapsed weeks later. At this time, episodes were more severe. Glycine receptor alpha 1 antibodies were found in serum (titer of 1:200, later 1:320) and cerebrospinal fluid (titer of 1:2). Treatment was restarted with intravenous steroids and immunoglobulins, with major improvement, and she began treatment with oral steroids. She had 4 milder relapses, with improvement after treatment adjustments. CONCLUSIONS AND RELEVANCE To our knowledge, this is the first pediatric case of progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor alpha 1 antibodies, a potentially severe but treatable antibody-mediated neurological disorder.</description><identifier>ISSN: 2168-6149</identifier><identifier>EISSN: 2168-6157</identifier><identifier>DOI: 10.1001/jamaneurol.2013.1872</identifier><identifier>PMID: 23380884</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Encephalomyelitis - blood ; Encephalomyelitis - cerebrospinal fluid ; Encephalomyelitis - complications ; Encephalomyelitis - drug therapy ; Female ; Follow-Up Studies ; Humans ; Immunoglobulins - blood ; Immunoglobulins - cerebrospinal fluid ; Immunoglobulins, Intravenous - therapeutic use ; Immunologic Factors - therapeutic use ; Infant ; Muscle Rigidity - blood ; Muscle Rigidity - cerebrospinal fluid ; Muscle Rigidity - complications ; Muscle Rigidity - drug therapy ; Myoclonus - blood ; Myoclonus - cerebrospinal fluid ; Myoclonus - complications ; Myoclonus - drug therapy ; Receptors, Glycine - immunology ; Severity of Illness Index ; Steroids - therapeutic use ; Treatment Outcome</subject><ispartof>JAMA neurology, 2013-04, Vol.70 (4), p.1-4</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamaneurology/articlepdf/10.1001/jamaneurol.2013.1872$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2013.1872$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,780,784,3340,27924,27925,76489,76492</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23380884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Damásio, Joana</creatorcontrib><creatorcontrib>Leite, M. Isabel</creatorcontrib><creatorcontrib>Coutinho, Ester</creatorcontrib><creatorcontrib>Waters, Patrick</creatorcontrib><creatorcontrib>Woodhall, Mark</creatorcontrib><creatorcontrib>Santos, Manuela A</creatorcontrib><creatorcontrib>Carrilho, Inês</creatorcontrib><creatorcontrib>Vincent, Angela</creatorcontrib><title>Progressive Encephalomyelitis With Rigidity and Myoclonus: The First Pediatric Case With Glycine Receptor Antibodies</title><title>JAMA neurology</title><addtitle>JAMA Neurol</addtitle><description>IMPORTANCE Progressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle spasms, hyperekplexia, and brainstem signs. Recently, glycine receptor alpha 1 antibodies have been described in adult patients with progressive encephalomyelitis with rigidity and myoclonus. We describe a pediatric case. OBSERVATIONS A 14-month-old child developed startle-induced episodes of generalized rigidity and myoclonus, axial hyperextension, and trismus, without impairment of consciousness. Episodes occurred during wakefulness and sleep, lasted seconds, and were accompanied by moaning, tachypnea, and oxygen desaturation. Imaging, cerebrospinal fluid, endocrine, metabolic, and genetic screening findings were normal or negative. She was treated with intravenous steroids and immunoglobulins with resolution of symptoms, but she relapsed weeks later. At this time, episodes were more severe. Glycine receptor alpha 1 antibodies were found in serum (titer of 1:200, later 1:320) and cerebrospinal fluid (titer of 1:2). Treatment was restarted with intravenous steroids and immunoglobulins, with major improvement, and she began treatment with oral steroids. She had 4 milder relapses, with improvement after treatment adjustments. CONCLUSIONS AND RELEVANCE To our knowledge, this is the first pediatric case of progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor alpha 1 antibodies, a potentially severe but treatable antibody-mediated neurological disorder.</description><subject>Encephalomyelitis - blood</subject><subject>Encephalomyelitis - cerebrospinal fluid</subject><subject>Encephalomyelitis - complications</subject><subject>Encephalomyelitis - drug therapy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunoglobulins - blood</subject><subject>Immunoglobulins - cerebrospinal fluid</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Infant</subject><subject>Muscle Rigidity - blood</subject><subject>Muscle Rigidity - cerebrospinal fluid</subject><subject>Muscle Rigidity - complications</subject><subject>Muscle Rigidity - drug therapy</subject><subject>Myoclonus - blood</subject><subject>Myoclonus - cerebrospinal fluid</subject><subject>Myoclonus - complications</subject><subject>Myoclonus - drug therapy</subject><subject>Receptors, Glycine - immunology</subject><subject>Severity of Illness Index</subject><subject>Steroids - therapeutic use</subject><subject>Treatment Outcome</subject><issn>2168-6149</issn><issn>2168-6157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LwzAch4MoTua-gIjk6GUzb00zbzI2FRRFJh5L0v7nIm0zk1Totzdjc-aSHJ7nF3gQuqRkQgmhN1-60S103tUTRiifUJWzI3TGqFRjSbP8-PAW0wEahfBF0lGECC5O0YBxrohS4gzFV-8-PYRgfwDP2xI2a127pofaRhvwh41r_GY_bWVjj3Vb4efelbVru3CLl2vAC-tDxK9QWR29LfFMB9hZ93Vf2hbwG6TR6Dy-a6M1rrIQztHJStcBRvt7iN4X8-XsYfz0cv84u3saa5ZncWyoYKUCw3IDmWCK87zUkoDKMp1zs8qzSgkjKBWJ0UYqkkuWDGmkXgHL-BBd73Y33n13EGLR2FBCXad2rgsF5QniVIhpQsUOLb0LwcOq2HjbaN8XlBTb5MV_8mKbvNgmT9rV_ofONFAdpL_ACbjYAcn-n8yklJTzX3F8iR8</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Damásio, Joana</creator><creator>Leite, M. Isabel</creator><creator>Coutinho, Ester</creator><creator>Waters, Patrick</creator><creator>Woodhall, Mark</creator><creator>Santos, Manuela A</creator><creator>Carrilho, Inês</creator><creator>Vincent, Angela</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130401</creationdate><title>Progressive Encephalomyelitis With Rigidity and Myoclonus: The First Pediatric Case With Glycine Receptor Antibodies</title><author>Damásio, Joana ; Leite, M. Isabel ; Coutinho, Ester ; Waters, Patrick ; Woodhall, Mark ; Santos, Manuela A ; Carrilho, Inês ; Vincent, Angela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a275t-b142c8eb27be5428337ca60e855a73bf75d84b4114eb2ab6807622c86b6afe253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Encephalomyelitis - blood</topic><topic>Encephalomyelitis - cerebrospinal fluid</topic><topic>Encephalomyelitis - complications</topic><topic>Encephalomyelitis - drug therapy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunoglobulins - blood</topic><topic>Immunoglobulins - cerebrospinal fluid</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Infant</topic><topic>Muscle Rigidity - blood</topic><topic>Muscle Rigidity - cerebrospinal fluid</topic><topic>Muscle Rigidity - complications</topic><topic>Muscle Rigidity - drug therapy</topic><topic>Myoclonus - blood</topic><topic>Myoclonus - cerebrospinal fluid</topic><topic>Myoclonus - complications</topic><topic>Myoclonus - drug therapy</topic><topic>Receptors, Glycine - immunology</topic><topic>Severity of Illness Index</topic><topic>Steroids - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Damásio, Joana</creatorcontrib><creatorcontrib>Leite, M. Isabel</creatorcontrib><creatorcontrib>Coutinho, Ester</creatorcontrib><creatorcontrib>Waters, Patrick</creatorcontrib><creatorcontrib>Woodhall, Mark</creatorcontrib><creatorcontrib>Santos, Manuela A</creatorcontrib><creatorcontrib>Carrilho, Inês</creatorcontrib><creatorcontrib>Vincent, Angela</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Damásio, Joana</au><au>Leite, M. Isabel</au><au>Coutinho, Ester</au><au>Waters, Patrick</au><au>Woodhall, Mark</au><au>Santos, Manuela A</au><au>Carrilho, Inês</au><au>Vincent, Angela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Progressive Encephalomyelitis With Rigidity and Myoclonus: The First Pediatric Case With Glycine Receptor Antibodies</atitle><jtitle>JAMA neurology</jtitle><addtitle>JAMA Neurol</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>70</volume><issue>4</issue><spage>1</spage><epage>4</epage><pages>1-4</pages><issn>2168-6149</issn><eissn>2168-6157</eissn><abstract>IMPORTANCE Progressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle spasms, hyperekplexia, and brainstem signs. Recently, glycine receptor alpha 1 antibodies have been described in adult patients with progressive encephalomyelitis with rigidity and myoclonus. We describe a pediatric case. OBSERVATIONS A 14-month-old child developed startle-induced episodes of generalized rigidity and myoclonus, axial hyperextension, and trismus, without impairment of consciousness. Episodes occurred during wakefulness and sleep, lasted seconds, and were accompanied by moaning, tachypnea, and oxygen desaturation. Imaging, cerebrospinal fluid, endocrine, metabolic, and genetic screening findings were normal or negative. She was treated with intravenous steroids and immunoglobulins with resolution of symptoms, but she relapsed weeks later. At this time, episodes were more severe. Glycine receptor alpha 1 antibodies were found in serum (titer of 1:200, later 1:320) and cerebrospinal fluid (titer of 1:2). Treatment was restarted with intravenous steroids and immunoglobulins, with major improvement, and she began treatment with oral steroids. She had 4 milder relapses, with improvement after treatment adjustments. CONCLUSIONS AND RELEVANCE To our knowledge, this is the first pediatric case of progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor alpha 1 antibodies, a potentially severe but treatable antibody-mediated neurological disorder.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>23380884</pmid><doi>10.1001/jamaneurol.2013.1872</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2168-6149
ispartof JAMA neurology, 2013-04, Vol.70 (4), p.1-4
issn 2168-6149
2168-6157
language eng
recordid cdi_proquest_miscellaneous_1325331449
source MEDLINE; American Medical Association Journals
subjects Encephalomyelitis - blood
Encephalomyelitis - cerebrospinal fluid
Encephalomyelitis - complications
Encephalomyelitis - drug therapy
Female
Follow-Up Studies
Humans
Immunoglobulins - blood
Immunoglobulins - cerebrospinal fluid
Immunoglobulins, Intravenous - therapeutic use
Immunologic Factors - therapeutic use
Infant
Muscle Rigidity - blood
Muscle Rigidity - cerebrospinal fluid
Muscle Rigidity - complications
Muscle Rigidity - drug therapy
Myoclonus - blood
Myoclonus - cerebrospinal fluid
Myoclonus - complications
Myoclonus - drug therapy
Receptors, Glycine - immunology
Severity of Illness Index
Steroids - therapeutic use
Treatment Outcome
title Progressive Encephalomyelitis With Rigidity and Myoclonus: The First Pediatric Case With Glycine Receptor Antibodies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T07%3A10%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Progressive%20Encephalomyelitis%20With%20Rigidity%20and%20Myoclonus:%20The%20First%20Pediatric%20Case%20With%20Glycine%20Receptor%20Antibodies&rft.jtitle=JAMA%20neurology&rft.au=Dam%C3%A1sio,%20Joana&rft.date=2013-04-01&rft.volume=70&rft.issue=4&rft.spage=1&rft.epage=4&rft.pages=1-4&rft.issn=2168-6149&rft.eissn=2168-6157&rft_id=info:doi/10.1001/jamaneurol.2013.1872&rft_dat=%3Cproquest_cross%3E1325331449%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1325331449&rft_id=info:pmid/23380884&rft_ama_id=1566613&rfr_iscdi=true